Pathogenetic mechanisms of metabolic disorders in patients with hypertension and obesity

dc.contributor.authorZlatkina, Vira
dc.contributor.authorNemtsova, Valeriya
dc.contributor.authorIlchenko, Iryna
dc.date.accessioned2018-11-01T14:19:16Z
dc.date.available2018-11-01T14:19:16Z
dc.date.issued2018
dc.description.abstractIt is important to study changes in the concentration of these cytokines in patients with arterial hypertension with type 2 diabetes or IR, namely at different stages of the disease progression, from the stage of disturbance of glucose regulation up to type 2 diabetes, which will enable doctors and scientists to overcome these diseases together, yet at the stage of laboratory changes to the occurrence of such serious complications as myocardial infarction and stroke, using a change in therapeutic tactics.ru_RU
dc.identifier.citationZlatkina V. V. Pathogenetic mechanisms of metabolic disorders in patients with hypertension and obesity / V. V. Zlatkina, V. D. Nemtsova, I. A. Ilchenko // Perspectives of science and education : Proceedings of the 5th International youth conference SLOVO\WORD, New York, USA, 19th October 2018. ꟷ New York, 2018. ꟷ P. 113ꟷ117.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/20833
dc.language.isoenru_RU
dc.subjectmetabolic syndromeru_RU
dc.subjectobesityru_RU
dc.subjecttype 2 diabetesru_RU
dc.subjectarterial hypertensionru_RU
dc.titlePathogenetic mechanisms of metabolic disorders in patients with hypertension and obesityru_RU
dc.typeThesisru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Zlatkina V. V. Pathogenetic mechanisms.pdf
Size:
475.32 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: